Christina Sheau Fen Wong

Title: Christina Sheau Fen Wong: Innovator in Cancer Therapy

Introduction

Christina Sheau Fen Wong is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of cancer therapy through her innovative research and development of targeted treatments. Her work focuses on the use of BCMA binders and CAR constructs to enhance the efficacy of cancer cell elimination.

Latest Patents

Christina holds a patent for "Compositions targeting BCMA and methods of use thereof." This invention relates to BCMA binders, such as antibodies, and chimeric antigen receptor (CAR) constructs that include a BCMA antigen binding molecule. The BCMA binders are designed to specifically bind to BCMA, and the CARs incorporate a hinge region, a transmembrane domain, and intracellular NK cell signaling domains. The NK cells expressing a BCMA CAR demonstrate increased efficacy in killing cancer cells. The patent also outlines therapeutic uses for the BCMA binders and CARs.

Career Highlights

Christina is currently employed at Takeda Pharmaceutical Company Limited, where she continues to advance her research in cancer therapies. Her work has positioned her as a key figure in the development of innovative treatments that target specific cancer markers.

Collaborations

Christina collaborates with notable colleagues, including Michael David Curley and Ertan Eryilmaz. Their combined expertise contributes to the advancement of research and development in the field of oncology.

Conclusion

Christina Sheau Fen Wong is a trailblazer in the realm of cancer treatment innovations. Her patent on BCMA-targeting compositions exemplifies her commitment to improving therapeutic outcomes for cancer patients. Her contributions to the field are invaluable and continue to inspire future advancements in medical research.